[PDF] Top 20 Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women
Has 10000 "Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women" found on our website. Below are the top 20 most common "Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women".
Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women
... those of the Million Women ...osteoporosis, and worry about side effects was often cited as a reason for stopping ...changes in the types of MHT used, which mostly consisted ... Voir le document complet
32
Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.
... that recent findings relating to the use of natural progesterone, in sharp contrast with those referring to the use of progestins, are ...two cohort studies carried out ... Voir le document complet
19
Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts Running title: Evolution of HT use in France
... included menopausal status and use (current and past) of hormonal treatments, as detailed ...Definition of menopause, HT initiation and periods compared Women were ... Voir le document complet
10
Should transdermal rather than oral estrogens be used in menopausal hormone therapy?: a review
... disease in a “cardiovascular disease” category because pulmonary embolism is a potentially fatal condition for which a link with MHT use is ...case-control and cohort ... Voir le document complet
29
Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.
... total of 1220 new-onset diabetes cases were validated during 663,087 person-years of follow-up (mean duration: ...selected characteristics of women according to their use ... Voir le document complet
16
Estimated numbers of postmenopausal women treated by hormone therapy in France.
... is in keeping with the general pattern of HT use since WHI and MWS’s ...results. In the last 15 years, HT use has increased consistently, particularly in France ... Voir le document complet
12
Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort
... strength of our study lies on the regular updates of exposure, which limited classification bias and allowed to account for possible changes over time in the types of hormones used by ... Voir le document complet
24
Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women.
... date of a positive association between a history of endometriosis and melanoma ...fibroma and melanoma, which has not been previously described, warrants further ...melanoma ... Voir le document complet
8
The recent evolution of foundations in France
... movements and 20 th Century Olympic movement, social protection, minority groups’ advocacy and environment defense ...vote in General Assembly, such as cooperatives, mutual societies and ... Voir le document complet
10
Anthropometry, breast cancer and menopausal status: use of repeated measurements over 10 years of follow-up-results of the French E3N women's cohort study.
... self-reported in each of the first 5 questionnaires and on height as recorded at ...recorded in each follow-up ...set of answers on date and type of menopause (natural or ... Voir le document complet
10
Characteristics of the size distribution of recent and historical landslides in a populated hilly region
... common in the Flemish Ardennes as, on average, they are recorded two to three times a year [4] ...initiation of deep-seated LS, on the other hand, was not recorded over the last 100 yr, and ... Voir le document complet
16
Hormone levels and cognitive function in postmenopausal midlife women.
... which, and the circumstances under which, endogenous and exogenous ovarian steroids affect cognitive function after natural menopause remains ...levels of estradiol decline as women enter the ... Voir le document complet
32
Title: Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
... Heart and Estrogen/progestin Replacement Study (HERS) Research ...Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's ... Voir le document complet
27
Cleaning and asthma characteristics in women.
... Genetics and Environment of Asthma, occupational exposure to cleaning products was associated with severe asthma at the baseline survey (EGEA1, 1991-1995) [Le Moual et ...phenotypic and exposure data ... Voir le document complet
22
Risk factors for onset of menopausal symptoms: results from a large cohort study.
... limitation of our study pertained to the absence of information on the type of menopausal ...symptoms. In our study, the term “menopausal symptoms” encompassed any symptom ... Voir le document complet
15
Effect of hormone replacement therapy on retinal and optic nerve head blood flow and topography in postmenopausal women, and retinal tissue perfusion in ovariectomized rats
... L’auteur a autorisé l’Université de Montréal à reproduire et diffuser, en totalité ou en partie, par quelque moyen que ce soit et sur quelque support que ce soit, et exclusivement à des fins non lucratives ... Voir le document complet
324
Treatment-resistant depression in a real-world setting: first interim analysis of characteristics, healthcare resource use, and utility values of the fondaMental cohort
... resource use 1. Introduction Major depressive disorder (MDD) is one of the most common psychiatric disorders, with a prevalence of ...9.8% in France in 2017 [ 1 ]. It is ... Voir le document complet
17
Mode of delivery and fecal incontinence at midlife: a study of 2,640 women in the Gazel cohort.
... Prevalence of combined fecal and urinary incontinence: a community-based ...Effect of Aging on Anorectal and Pelvic Floor Functions in ... Voir le document complet
21
Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
... ER-PR- and ER+PR+ breast cancer [3,14]. In the current analysis, we also observed an inverse risk association for both ER-PR- and ER+PR+ malignancies with a longer cumu- lative duration ... Voir le document complet
13
Breast cancer and hormonal therapy in postmenopausal women
... is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or ...teaching and research institutions ... Voir le document complet
3
Sujets connexes